Rhumbline Advisers Sight Sciences, Inc. Transaction History
Rhumbline Advisers
- $109 Billion
- Q4 2024
A detailed history of Rhumbline Advisers transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 45,478 shares of SGHT stock, worth $123,245. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,478
Previous 44,374
2.49%
Holding current value
$123,245
Previous $279,000
40.86%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding SGHT
# of Institutions
80Shares Held
21.3MCall Options Held
66.8KPut Options Held
13K-
Kck Ltd. Tortola, D84.37MShares$11.9 Million21.26% of portfolio
-
Ubs Group Ag2.53MShares$6.86 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.12MShares$5.75 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.1MShares$5.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.69MShares$4.58 Million0.0% of portfolio
About Sight Sciences, Inc.
- Ticker SGHT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,826,200
- Market Cap $130M
- Description
- Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...